Literature DB >> 23943783

High-fat, high-calorie diet promotes early pancreatic neoplasia in the conditional KrasG12D mouse model.

David W Dawson1, Kathleen Hertzer, Aune Moro, Graham Donald, Hui-Hua Chang, Vay Liang Go, Steven J Pandol, Aurelia Lugea, Anna S Gukovskaya, Gang Li, Oscar J Hines, Enrique Rozengurt, Guido Eibl.   

Abstract

There is epidemiologic evidence that obesity increases the risk of cancers. Several underlying mechanisms, including inflammation and insulin resistance, are proposed. However, the driving mechanisms in pancreatic cancer are poorly understood. The goal of the present study was to develop a model of diet-induced obesity and pancreatic cancer development in a state-of-the-art mouse model, which resembles important clinical features of human obesity, for example, weight gain and metabolic disturbances. Offspring of Pdx-1-Cre and LSL-KrasG12D mice were allocated to either a high-fat, high-calorie diet (HFCD; ∼4,535 kcal/kg; 40% of calories from fats) or control diet (∼3,725 kcal/kg; 12% of calories from fats) for 3 months. Compared with control animals, mice fed with the HFCD significantly gained more weight and developed hyperinsulinemia, hyperglycemia, hyperleptinemia, and elevated levels of insulin-like growth factor I (IGF-I). The pancreas of HFCD-fed animals showed robust signs of inflammation with increased numbers of infiltrating inflammatory cells (macrophages and T cells), elevated levels of several cytokines and chemokines, increased stromal fibrosis, and more advanced PanIN lesions. Our results show that a diet high in fats and calories leads to obesity and metabolic disturbances similar to humans and accelerates early pancreatic neoplasia in the conditional KrasG12D mouse model. This model and findings will provide the basis for more robust studies attempting to unravel the mechanisms underlying the cancer-promoting properties of obesity, as well as to evaluate dietary- and chemopreventive strategies targeting obesity-associated pancreatic cancer development.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23943783      PMCID: PMC3835151          DOI: 10.1158/1940-6207.CAPR-13-0065

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  40 in total

Review 1.  Progression model for pancreatic cancer.

Authors:  R H Hruban; M Goggins; J Parsons; S E Kern
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

Review 2.  Genetically engineered mouse models: closing the gap between preclinical data and trial outcomes.

Authors:  Mallika Singh; Christopher L Murriel; Leisa Johnson
Journal:  Cancer Res       Date:  2012-05-16       Impact factor: 12.701

3.  Promoting effect of a high-fat/high-protein diet in DMBA-induced ductal pancreatic cancer in rats.

Authors:  K Z'graggen; A L Warshaw; J Werner; F Graeme-Cook; R E Jimenez; C Fernández-Del Castillo
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

4.  Obesity, but not high-fat diet, promotes murine pancreatic cancer growth.

Authors:  Patrick B White; Kathryn M Ziegler; Deborah A Swartz-Basile; Sue S Wang; Keith D Lillemoe; Henry A Pitt; Nicholas J Zyromski
Journal:  J Gastrointest Surg       Date:  2012-06-12       Impact factor: 3.452

Review 5.  Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies.

Authors:  A Mohammed; N B Janakiram; S Lightfoot; H Gali; A Vibhudutta; C V Rao
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

6.  Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions.

Authors:  R H Hruban; N V Adsay; J Albores-Saavedra; C Compton; E S Garrett; S N Goodman; S E Kern; D S Klimstra; G Klöppel; D S Longnecker; J Lüttges; G J Offerhaus
Journal:  Am J Surg Pathol       Date:  2001-05       Impact factor: 6.394

7.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

8.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

9.  Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.

Authors:  Belinda Gier; Aleksey V Matveyenko; David Kirakossian; David Dawson; Sarah M Dry; Peter C Butler
Journal:  Diabetes       Date:  2012-01-20       Impact factor: 9.461

10.  Metastatic pancreatic cancer is dependent on oncogenic Kras in mice.

Authors:  Meredith A Collins; Jean-Christophe Brisset; Yaqing Zhang; Filip Bednar; Josette Pierre; Kevin A Heist; Craig J Galbán; Stefanie Galbán; Marina Pasca di Magliano
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

View more
  61 in total

1.  Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions.

Authors:  Geou-Yarh Liou; Heike Döppler; Brian Necela; Brandy Edenfield; Lizhi Zhang; David W Dawson; Peter Storz
Journal:  Cancer Discov       Date:  2014-10-31       Impact factor: 39.397

2.  Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.

Authors:  Hui-Hua Chang; Steven H Young; James Sinnett-Smith; Caroline Ei Ne Chou; Aune Moro; Kathleen M Hertzer; Oscar Joe Hines; Enrique Rozengurt; Guido Eibl
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-26       Impact factor: 4.249

Review 3.  Cholecystokinin and pancreatic cancer: the chicken or the egg?

Authors:  Jill P Smith; Travis E Solomon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-31       Impact factor: 4.052

4.  E-cadherin expression in obesity-associated, Kras-initiated pancreatic ductal adenocarcinoma in mice.

Authors:  Alexander P Stark; Hui-Hua Chang; Xiaoman Jung; Aune Moro; Kathleen Hertzer; Mu Xu; Andrea Schmidt; O Joe Hines; Guido Eibl
Journal:  Surgery       Date:  2015-08-18       Impact factor: 3.982

5.  Insulin promotes proliferation and fibrosing responses in activated pancreatic stellate cells.

Authors:  Jiayue Yang; Richard T Waldron; Hsin-Yuan Su; Aune Moro; Hui-Hua Chang; Guido Eibl; Kevin Ferreri; Fouad R Kandeel; Aurelia Lugea; Ling Li; Stephen J Pandol
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-08       Impact factor: 4.052

6.  The Presence of Interleukin-13 at Pancreatic ADM/PanIN Lesions Alters Macrophage Populations and Mediates Pancreatic Tumorigenesis.

Authors:  Geou-Yarh Liou; Ligia Bastea; Alicia Fleming; Heike Döppler; Brandy H Edenfield; David W Dawson; Lizhi Zhang; Nabeel Bardeesy; Peter Storz
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

7.  Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat.

Authors:  Gail L Matters; Timothy K Cooper; Christopher O McGovern; Evan L Gilius; Jiangang Liao; Brian M Barth; Mark Kester; Jill P Smith
Journal:  Dig Dis Sci       Date:  2014-05-11       Impact factor: 3.199

8.  Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene.

Authors:  Chen Liang; Zhen Wang; Li Wu; Chen Wang; Bao-Hua Yu; Xiu-Zhong Yao; Xiao-Lin Wang; Ying-Yi Li
Journal:  Tumour Biol       Date:  2015-04-29

9.  Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity.

Authors:  Tien S Dong; Hui-Hua Chang; Meg Hauer; Venu Lagishetty; William Katzka; Enrique Rozengurt; Jonathan P Jacobs; Guido Eibl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

Review 10.  Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality.

Authors:  Timothy R Donahue; David W Dawson
Journal:  Trends Endocrinol Metab       Date:  2016-07-25       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.